Main competitors
1m. Revenue rev. 4m. EPS revision 4m. Revenue rev. 1y. EPS revision 1y. Revenue rev. Visibility Nbr of analysts
- 1
10
7
- 1
10
5
2
5
3
- -
- -
Average 5
Weighted average by Cap. 7
Bio Diagnostics & Testing
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!